EQ Stock Analysis: Buy, Sell, or Hold?
EQ - Equillium, Inc. Common Stock
$2.84
-0.02 (-0.70%)
▼
5d:
+1.43%
30d:
+28.51%
90d:
+40.59%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When EQ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EQ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: EQ shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: EQ is currently trading at $2.84, which is considered fair relative to its 30-day fair value range of $2.28 to $3.04.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $2.23, while resistance sits at $3.45.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.12 (+150.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EQ is in a strong uptrend. Immediate support is located at $2.23, while resistance sits at $3.45.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.12 (+150.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.28 -
$3.04
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 150.9% below Wall St target ($7.12)
Trading Range Analysis
30-Day Trading Range
$2.28 -
$3.04
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.23
Resistance Level
$3.45
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.85
Wall Street Target
$7.13
(+150.9%)
Revenue Growth (YoY)
-52.3%
Share & Embed Analysis
Last updated: June 23, 2026 11:44 PM ET
Data refreshes hourly during market hours. Next update: 12:44 AM
Data refreshes hourly during market hours. Next update: 12:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EQ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Christine Zedelmayer
SELL
120312 shares
2026-03-13
Christine Zedelmayer
SELL
181219 shares
2026-03-09
Christine Zedelmayer
SELL
185937 shares
2026-02-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 65 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 63 BUY |